Ling Tang
Impact in
-
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- Ophthalmology top 10%
- Retinal Diseases and Treatments
Papers in
-
- Advanced biosensing and bioanalysis techniques 3
- Ubiquitin and proteasome pathways 2
- RNA modifications and cancer 2
-
- Biosensors and Analytical Detection 3
- Co-authors
- Rong Cai (1 shared paper)Bingyi Lin (1 shared paper)Shuming Hu (1 shared paper)Denis M. Medeiros (1 shared paper)Dingbo Lin (1 shared paper)Lloyd Willard (1 shared paper)Yunong Zhang (1 shared paper)Yu Jiang (1 shared paper)
- Journals
- Experimental Biology and Medicine (1 paper)Gene (1 paper)Skin Pharmacology and Physiology (1 paper)Neuropeptides (1 paper)Cancer Cell International (1 paper)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Ling Tang
16 papers receiving 408 citations
Ling Tang's Hit Papers
Peers
Comparison fields: 5 of 79
- Cancer Research 76
- Ophthalmology 43
- Biochemistry 30
- Pulmonary and Respiratory Medicine 116
- Clinical Biochemistry 20
Countries citing papers authored by Ling Tang
This map shows the geographic impact of Ling Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Tang more than expected).
Fields of papers citing papers by Ling Tang
This network shows the impact of papers produced by Ling Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Tang. The network helps show where Ling Tang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | NRF2, a Superstar of Ferroptosis Hit paper breakdown → | 2023 | 143 |
| 2 | 2011 | 114 | |
| 3 | 2010 | 46 | |
| 4 | 2019 | 33 | |
| 5 | 2019 | 22 | |
| 6 | 2020 | 16 | |
| 7 | 2009 | 10 | |
| 8 | 2021 | 9 | |
| 9 | 2018 | 5 | |
| 10 | Study on Youchasaponin-induced apoptosis of HepG2 cells through the endoplasmic reticulum stress | 2011 | 4 |
| 11 | Youchasaponin induces apoptosis of human leukemia Jurkat cells in vitro and its possible mechanism | 2011 | 2 |
| 12 | 2022 | 2 | |
| 13 | 2017 | 2 | |
| 14 | 2018 | 2 | |
| 15 | Effects of soybean isoflavone on growth factors and its receptor on prostatic hyperplasia in rats. | 2010 | 1 |
| 16 | Sasanguasaponin-induced apoptosis of Jurkat cells through endoplasmic reticulum stress | 2012 | 1 |
About Ling Tang
Ling Tang is a scholar working on Molecular Biology, Biomedical Engineering, Oncology, Pharmacology and Pathology and Forensic Medicine, having authored 16 papers that have together received 412 indexed citations. Recurring topics across this work include Biosensors and Analytical Detection (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), Ubiquitin and proteasome pathways (2 papers), Cancer-related Molecular Pathways (2 papers), RNA modifications and cancer (2 papers), Sirtuins and Resveratrol in Medicine (1 paper), Genetics and Neurodevelopmental Disorders (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Cancer Research (76 citations), Ophthalmology (43 citations), Biochemistry (30 citations), Pulmonary and Respiratory Medicine (116 citations) and Clinical Biochemistry (20 citations). Ling Tang has collaborated with scholars based in China, United States and France. Frequent co-authors include Rong Cai, Bingyi Lin, Shuming Hu, Denis M. Medeiros, Dingbo Lin, Lloyd Willard, Yunong Zhang, Yu Jiang, Yuquan Jiang and Zheng Jiang. Their work appears in journals such as Experimental Biology and Medicine, Gene, Skin Pharmacology and Physiology, Neuropeptides and Cancer Cell International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.